Interacciones de Cefoxitina

Cefoxitina (Mefoxin), cefalosporina, tiene 63 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 27; moderadas: 35; leves: 1; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (27)

  • Amoxicilinaantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • Amoxicilina y ácido clavulánicoantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • Ampicilinaantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • Ampicilina y sulbactamantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefaclorcefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefadroxilocefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefalexinacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefazolinacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefdinircefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefepimacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefiximacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefotaximacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefotetáncefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefpodoximacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefprozilocefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CeftarolinacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CeftazidimacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CeftriaxonacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • CefuroximacefalosporinaGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • Dicloxacilinaantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • ErtapenemantibióticoGrave

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (etiqueta de Ertapenem, Contraindicaciones)

  • Imipenem y cilastatinaantibióticoGrave

    Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (etiqueta de Imipenem y cilastatina, Advertencias y precauciones)

  • Nafcilinaantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • Oxacilinaantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • Penicilina Gantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • Penicilina Vantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

  • Piperacilina y tazobactamantibiótico del grupo de las penicilinasGrave

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (etiqueta de Cefoxitina, Contraindicaciones)

Interacciones moderadas (35)

  • Ácido etacrínicodiurético de asaModerada

    Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (etiqueta de Ácido etacrínico, Interacciones medicamentosas)

  • AmikacinaaminoglucósidoModerada

    Aminoglycosides: Increased potential of nephrotoxicity. (etiqueta de Cefoxitina, Interacciones medicamentosas)

  • Azelastina y fluticasonaantihistamínicoModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • AztreonamantibióticoModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • BeclometasonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • BetametasonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • BudesonidacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • Budesonida y formoterolcorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • CiclesonidacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • ClobetasolcorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • DeflazacortcorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • DesonidacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • DexametasonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • FludrocortisonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • FlunisolidacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • FluocinonidacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • FluticasonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • Fluticasona y salmeterolcorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • Furosemidadiurético de asaModerada

    Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (etiqueta de Furosemida, Interacciones medicamentosas)

  • GentamicinaaminoglucósidoModerada

    Aminoglycosides: Increased potential of nephrotoxicity. (etiqueta de Cefoxitina, Interacciones medicamentosas)

  • HalobetasolcorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • HidrocortisonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • MetilprednisolonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • MicofenolatoinmunosupresorModerada

    Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (etiqueta de Micofenolato, Interacciones medicamentosas)

  • MometasonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • NeomicinaaminoglucósidoModerada

    Aminoglycosides: Increased potential of nephrotoxicity. (etiqueta de Cefoxitina, Interacciones medicamentosas)

  • Olopatadina y mometasonaantihistamínicoModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • PlazomicinaaminoglucósidoModerada

    Aminoglycosides: Increased potential of nephrotoxicity. (etiqueta de Cefoxitina, Interacciones medicamentosas)

  • PrednisolonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • PrednisonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

  • ProbenecidModerada

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (etiqueta de Probenecid, Interacciones medicamentosas)

  • DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (etiqueta de Probenecid y colchicina, Interacciones medicamentosas)

  • ProtaminaModerada

    Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (etiqueta de Protamina, Precauciones)

  • TobramicinaaminoglucósidoModerada

    Aminoglycosides: Increased potential of nephrotoxicity. (etiqueta de Cefoxitina, Interacciones medicamentosas)

  • TriamcinolonacorticosteroideModerada

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (etiqueta de Cefoxitina, Advertencias y precauciones)

Menciones leves (1)

  • MeropenemantibióticoLeve

    Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (etiqueta de Meropenem, Advertencias y precauciones)

Compruebe Cefoxitina frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.